Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. The activation of human plasminogen. I. Spontaneous activation in glycerol. J Biol Chem. 1958 Jul;233(1):81–85. [PubMed] [Google Scholar]
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
- AMBRUS J. L., AMBRUS C. M., BACK N., SOKAL J. E., COLLINS G. L. Clinical and experimental studies on fibrinolytic enzymes. Ann N Y Acad Sci. 1957 Aug 30;68(1):97–137. doi: 10.1111/j.1749-6632.1957.tb42616.x. [DOI] [PubMed] [Google Scholar]
- BACH N., AMBRUS J. L., SIMPSON C. L., SHULMAN S. Study on the effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization. J Clin Invest. 1958 Jun;37(6):864–871. doi: 10.1172/JCI103677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CARTER J. R., WARNER E. D. Correction by defects in clotting accelerator activity by administration of methionine and vitamin K and of a new sulfhydryl-substituted methylnaphthoquinone, vitamin K-S(II). J Clin Invest. 1958 Jan;37(1):70–86. doi: 10.1172/JCI103587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CLIFFTON E. E. The use of plasmin in humans. Ann N Y Acad Sci. 1957 Aug 30;68(1):209–229. doi: 10.1111/j.1749-6632.1957.tb42627.x. [DOI] [PubMed] [Google Scholar]
- DEUTSCH E., SCHADEN W. Zur Reingung und Charakterisierung des VII. Blutgerinnungsfaktors. Biochem Z. 1953;324(4):266–279. [PubMed] [Google Scholar]
- FLETCHER A. P., ALKJAERSIG N., SHERRY S. The clearance of heterologous protein from the circulation of normal and immunized man. J Clin Invest. 1958 Sep;37(9):1306–1315. doi: 10.1172/JCI103719. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FLETCHER A. P., JOHNSON A. J. Methods employed for purification of streptokinase. Proc Soc Exp Biol Med. 1957 Jan;94(1):233–236. doi: 10.3181/00379727-94-22909. [DOI] [PubMed] [Google Scholar]
- FLETCHER A. P., SHERRY S., ALKJAERSIG N., SMYRNIOTIS F. E., JICK S. The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders. J Clin Invest. 1959 Jul;38(7):1111–1119. doi: 10.1172/JCI103887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- JOHNSON A. J., FLETCHER A. P., MCCARTY W. R., TILLETT W. S. Effects in patients of intravenous infusions of purified streptokinase preparations. Proc Soc Exp Biol Med. 1957 Feb;94(2):254–258. doi: 10.3181/00379727-94-22913. [DOI] [PubMed] [Google Scholar]
- JOHNSON A. J., FLETCHER A. P., McCARTY W. R., TILLETT W. S. The intravascular use of streptokinase. Ann N Y Acad Sci. 1957 Aug 30;68(1):201–208. doi: 10.1111/j.1749-6632.1957.tb42626.x. [DOI] [PubMed] [Google Scholar]
- JOHNSON A. J., TILLETT W. S. The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). J Exp Med. 1952 May 1;95(5):449–464. doi: 10.1084/jem.95.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KARMEN A., WROBLEWSKI F., LADUE J. S. Transaminase activity in human blood. J Clin Invest. 1955 Jan;34(1):126–131. doi: 10.1172/JCI103055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KELLNER A., ROBERTSON T. Selective necrosis of cardiac and skeletal muscle induced experimentally by means of proteolytic enzyme solutions given intravenously. J Exp Med. 1954 Apr 1;99(4):387–404. doi: 10.1084/jem.99.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOELIGER A., HERS J. F. Chronic antithrombinaemia (Antithrombin V) with Haemorrhagic diathesis in a case of rheumatoid arthritis with hypergammaglobulinaemia). Thromb Diath Haemorrh. 1957 Dec 15;1(3-4):499–528. [PubMed] [Google Scholar]
- MULLERTZ S. Fibrinolytic activity of human blood after death. Acta Physiol Scand. 1952;27(2-3):265–271. doi: 10.1111/j.1748-1716.1953.tb00942.x. [DOI] [PubMed] [Google Scholar]
- MULLERTZ S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem J. 1955 Nov;61(3):424–434. doi: 10.1042/bj0610424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SEEGERS W. H., JOHNSON J. F., FELL C. An antithrombin reaction to prothrombin activation. Am J Physiol. 1954 Jan;176(1):97–103. doi: 10.1152/ajplegacy.1953.176.1.97. [DOI] [PubMed] [Google Scholar]
- SHERRY S., ALKJAERSIG N. Biochemical experimental, and clinical studies of proteolytic enzymes with particular reference to the fibrinolytic enzyme of human plasma. Ann N Y Acad Sci. 1957 Aug 30;68(1):52–66. doi: 10.1111/j.1749-6632.1957.tb42612.x. [DOI] [PubMed] [Google Scholar]
- SHERRY S., ALKJAERSIG N. Studies on the fibrinolytic enzyme of human plasma. Thromb Diath Haemorrh. 1957 Aug 15;1(2):264–288. [PubMed] [Google Scholar]
- SHERRY S., LINDEMEYER R. I., FLETCHER A. P., ALKJAERSIG N. Studies on enhanced fibrinolytic activity in man. J Clin Invest. 1959 May;38(5):810–822. doi: 10.1172/JCI103863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SHERRY S., TITCHENER A., GOTTESMAN L., WASSERMAN P., TROLL W. The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators. J Clin Invest. 1954 Oct;33(10):1303–1313. doi: 10.1172/JCI103006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TILLETT W. S., JOHNSON A. J., McCARTY W. R. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J Clin Invest. 1955 Feb;34(2):169–185. doi: 10.1172/JCI103071. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TROLL W., SHERRY S. The activation of human plasminogen by streptokinase. J Biol Chem. 1955 Apr;213(2):881–891. [PubMed] [Google Scholar]
- VON KAULLA K. N., SWAN H. Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant. J Thorac Surg. 1958 Oct;36(4):519–530. [PubMed] [Google Scholar]